Bulletin of the World Health Organization

Management of diabetes and associated cardiovascular risk factors in seven countries: a comparison of data from national health examination surveys

Emmanuela Gakidou, Leslie Mallinger, Jesse Abbott-Klafter, Ramiro Guerrero, Salvador Villalpando, Ruy Lopez Ridaura, Wichai Aekplakorn, Mohsen Naghavi, Stephen Lim, Rafael Lozano & Christopher JL Murray

Volume 89, Number 3, March 2011, 172-183

Table 4. Comparison of diagnostic thresholds for diabetes and treatment targets for blood glucose, systolic blood pressure (BP) and serum cholesterol across national guidelines in seven-country study of the management of diabetes and associated cardiovascular risk factors

National guideline (country, issuing body, year of publication)	Diagnostic threshold, FPG (mg/dl)	Treatment target
	Diagnostic threshold, FPG (mg/dl)	Blood glucose (HbA1c or FPG)	Systolic BP (mmHg)	Serum lipids (mmol/l)
Colombia, Ministry of Social Protection,²⁸ 2007	≥ 126	< 7.0% HbA1c	< 140	LDL < 2.6
England and Scotland, National Institute for Clinical Excellence,²⁹ 2008	NA	< 6.5–7.5% HbA1c	< 140	LDL < 3.0
				TC < 5.0
				TG < 2.3
Islamic Republic of Iran, Ministry of Health,³⁰ 2004	≥ 126	< 140 mg/dl FPG	< 130	LDL < 3.4
				TC < 6.2
				TG < 2.3
Mexico, Ministry of Health,³¹ 1994	≥ 126	< 140 mg/dl FPG	< 130	TC < 6.2
				TG < 2.3
				HDL > 0.9
Thailand, National Health Security Office,³² 2008	≥ 126	< 6.5% HbA1c; 70–110 mg/dl FPG	< 130	LDL < 2.6
				TC 3.4–4.4
				TG < 1.7
				HDL ≥ 1.0
United States, American Diabetes Association,³³ 2009	≥ 126	< 7.0% HbA1c	< 130	LDL < 2.6
				TG < 1.7
				HDL > 1.0
World, International Diabetes Federation,²⁶ 2005	≥ 126	< 6.5% HbA1c; < 110 mg/dl FPG	< 130	LDL < 2.5
				TG < 2.3
				HDL > 1.0

FPG, fasting plasma glucose; HbA1c, glycosylated haemoglobin; HDL, high-density lipoprotein; LDL, low-density lipoprotein; mg/dl, milligrams per decilitre; mmHg, millimetres of mercury; mmol/l, millimoles per litre; NA, not available; TC, total cholesterol; TG, triglycerides.